Publications:32
Shyamala Navada, MD, MSCR
About Me
Dr. Navada is an Adjunct Associate Professor in the Department of Medicine
Language
English
Position
ADJUNCT ASSOCIATE PROFESSOR | Medicine, Hematology and Medical Oncology
Research Topics
Cancer, Leukemia
Clinical Focus
- Anemia
- Aplastic Anemia
- Blood Transfusion
- Bone Marrow Biopsy
- Leukemia
- Myelodysplastic Syndromes
- Primary Polycythemia
Publications
Selected Publications
- Modulation of the clonal burden in patients with lower-risk myelodysplastic neoplasms treated with imetelstat. Valeria Santini, Amer M. Zeidan, Koen Van Eygen, Pierre Fenaux, Ulrich Germing, Yazan F. Madanat, Azra Raza, Michael R. Savona, Mikkael A. Sekeres, Sylvain Thépot, Marco G. Raddi, Thomas Boyer, Libo Sun, Ying Wan, Tymara Berry, Qi Xia, Fei Huang, Souria Dougherty, Shyamala Navada, Faye Feller, Rami S. Komrokji, Uwe Platzbecker. Leukemia
- Effect of prior therapy on the clinical activity of imetelstat in patients with transfusion-dependent, ESA-relapsed or -refractory/-ineligible LR-MDS. Rami S. Komrokji, Valeria Santini, Amer M. Zeidan, Mikkael A. Sekeres, Pierre Fenaux, Azra Raza, Moshe Mittelman, Sylvain Thépot, Rena Buckstein, Ulrich Germing, Yazan F. Madanat, María Díez-Campelo, David Valcárcel, Anna Jonášová, Souria Dougherty, Sheetal Shah, Qi Xia, Libo Sun, Shyamala Navada, Faye Feller, Michael R. Savona, Uwe Platzbecker. Blood Cancer Journal
- Transfusion Independence Corresponds With Survival in Patients With Lower-Risk Myelodysplastic Syndrome: Real-World Evidence From United States Insurance Claims. Rami S. Komrokji, Dylan Supina, Shyamala Navada, Ravi Potluri, Rohit Tyagi, Tim Werwath, Zhuoer Xie, Eric Padron, David A. Sallman. Clinical Lymphoma, Myeloma and Leukemia
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Navada during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Outside Employment
- Geron Corporation
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.